AESKUCARE
DEAD

Serial Number

88066258

Owner

Aeneas GmbH & Co. KG

Attorney

Ralph G. Fischer

Filing Date

Aug 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

AESKUCARE Trademark

Serial Number: 88066258

AESKUCARE is a trademark filed by Aeneas GmbH & Co. KG on August 6, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Aeneas GmbH & Co. KG (12 trademarks)

Mikroforum Ring 2
Wendelsheim 55234 , DE

Entity Type: 03

Trademark Details

Filing Date

August 6, 2018

Registration Date

Not Registered

Goods & Services

Diagnostic, examination, and monitoring equipment, namely, automotive testing equipment, namely, handheld diagnostic scanners; Laboratory apparatus for the transmission of liquids, namely, laboratory glassware for medical research purposes; Laboratory apparatus for mixing liquids, namely, laboratory mixers used for medical research purposes; Laboratory apparatus for thinning liquids, namely, centrifuges; Apparatus for incubating liquids, namely, constant temperature incubators for laboratory use

Medical apparatus and instruments for analyzing autoimmune diseases, neurological diseases, cardiovascular diseases or cancer; Analysers for medical use, namely, medical instruments for analyzing and identifying autoimmune diseases, brain diseases, cardiovascular diseases or cancer; Diagnostic apparatus for medical purposes for detecting cancer; Automated testing apparatus for bodily fluids in the nature of blood testing apparatus for medical or medical diagnostic purposes; Diagnostic, examination, and monitoring equipment, namely, pipettes, monitors for visualizing DNA, RNA, proteins, cells, bacteria, bodily fluids or tissues, and microscopes for medical purposes; Laser pointers for medical use; Laser beam delivery instruments for medical use, namely, lasers for surgical and medical use; Medical instruments, namely, medical diagnostic instruments for the analysis of blood or bodily fluids; Medical instruments incorporating lasers, namely, lasers for medical use; Tools for medical diagnostics, namely, ultrasound diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; Apparatus for carrying-out diagnostic tests for medical purposes, namely, medical instruments for autoimmune diagnostics, neurological diagnostics, cardiovascular diagnostics or cancer diagnostics; Apparatus for analysing images for medical use, namely, medical imaging apparatus; Apparatus for DNA and RNA testing for medical purposes; Apparatus for analysing bacteria in biological samples for medical use; Capillary tubes for delivering reagents; Specimen cup holders; Apparatus for the transmission of liquids, namely, blood containers for medical or medical diagnostic purposes; Apparatus for mixing liquids, namely, blood roller mixers for medical or medical diagnostic purposes; Apparatus for administering liquids, namely, pipettes, automatic pipettes, robotic devices for liquid transfer, dispensing, mixing, absorption or resorption, and medical instruments for liquid transfer, dispensing, mixing, absorption or resorption, all for medical or medical diagnostic purposes; Apparatus for thinning liquids, namely, centrifuges for medical or medical diagnostic purposes; Apparatus in the nature of incubators for incubating liquids, for medical or medical diagnostic purposes; Immunological testing apparatus for medical use; Electronic analyzers for medical purposes, namely, instruments for analyzing and identifying DNA, RNA, proteins, cells, bacteria, bodily fluids, tissues, autoimmune diseases, neurological diseases, cardiovascular diseases or cancer; Photometric analyzers for medical use, namely, instruments for analyzing and identifying DNA, RNA, proteins, cells, bacteria, bodily fluids, tissues, autoimmune diseases, neurological diseases, cardiovascular diseases, or cancer; Automatic analyzers for medical diagnosis, namely, instruments for analyzing and identifying DNA, RNA, proteins, cells, bacteria, bodily fluids, tissues, autoimmune diseases, neurological diseases, cardiovascular diseases, or cancer; Body composition analyzers for medical purposes; Analysers for bacterial identification for medical purposes; Physical analyzers for medical use, namely, instruments for analyzing and identifying DNA, RNA, proteins, cells, bacteria, bodily fluids, tissues, autoimmune diseases, neurological diseases, cardiovascular diseases, or cancer; Blood centrifuging tubules for medical use; Blood filters for extracorporeal use; Hypodermic needles; Medication fluid injectors; Medical fluid injectors for medical or medical diagnostic purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 25, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 25, 2026 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 23, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 23, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 23, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 28, 2025 RCCK
ASSIGNED TO EXAMINER
Dec 8, 2025 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 27, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 27, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jun 27, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 26, 2025 ERSI
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 17, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2025 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 2, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 2, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 2, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
Dec 2, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 27, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 28, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 28, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 28, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 29, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 29, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 29, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2024 CRFA
ASSIGNED TO LIE
Jan 29, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 18, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 15, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 15, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
May 15, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 14, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 14, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 14, 2022 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 17, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 17, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 17, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 11, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 16, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 16, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 16, 2021 CNSI
ASSIGNED TO EXAMINER
Nov 15, 2021 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 8, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 5, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 5, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 5, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 20, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 4, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 4, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 4, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2020 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 2, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 15, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 15, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 15, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 15, 2019 RCCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2019 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 30, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 30, 2019 GNSL
SUSPENSION LETTER WRITTEN
Mar 30, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2019 CRFA
ASSIGNED TO LIE
Mar 15, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 13, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 13, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 13, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2018 NWOS
NEW APPLICATION ENTERED
Aug 9, 2018 NWAP